Mucosa

The moist inner lining of the gut. In Crohn's this lining becomes inflamed and ulcerated.

Also called: mucosal, gut lining, bowel lining, lining of the gut

Related words mucosal healing ulcer transmural

Topics About Crohn's disease

Questions people ask

What does 'treat to target' mean?

It means your team agrees goals in advance and adjusts treatment until you reach them, rather than waiting for symptoms. The STRIDE-II expert agreement says early goals are feeling better and getting blood and poo inflammation tests back to normal; longer-term goals are a healed bowel lining, no disability, good quality of life and normal growth in children. The CALM trial found that stepping up treatment when tests showed inflammation, not just when symptoms flared, led to more bowel healing.

Sources

Why do I still need tests when I feel well?

Symptoms do not always match what is happening inside. Crohn's & Colitis UK says calprotectin can be raised even without symptoms, and tests check for anaemia and medicine side effects. Some teams use a 'treat to target' approach, aiming for healing of the gut lining and normal markers rather than just fewer symptoms. Monitoring may include blood and poo tests, scans, colonoscopy and, in some hospitals, home calprotectin kits.

Sources

What happens during a colonoscopy?

A specialist passes a thin, flexible tube with a camera through your bottom to look at the lining of your bowel and take tiny tissue samples (biopsies). The day before, you take laxatives (bowel prep) to empty the bowel, and you will be told what to eat and drink. Crohn's & Colitis UK says it is worth going even if your symptoms have eased, because inflammation can still be found. Biopsy results can take several weeks.

Sources

Where to read more

Medical words

Crohn's & Colitis UK Web page Mar 2025 For patients

An A to Z glossary of the medical terms you are likely to see in clinic letters and reports, explained in plain words. It covers parts of the gut such as the ileum and caecum, findings like granulomas, strictures and fistulas, and terms such as flare-up and relapse.

Topics About Crohn's disease

Jargon explained ileum caecum granuloma fistula stricture mucosa relapse

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

Journal of Crohn's and Colitis via PubMed Central Systematic review Feb 2020 For professionals

Reviews the evidence for 'treat to target', where treatment is adjusted not just to symptoms but to measured goals such as a healed bowel lining and normal blood or poo markers. It explains the idea behind the STRIDE targets and notes that firm proof that aiming for healing improves long-term outcomes was still emerging.

Topics Monitoring Research

Jargon explained treat to target mucosal healing biomarker STRIDE

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD)

Gastroenterology Guideline Apr 2021 For professionals

An international expert agreement on what 'treat to target' should aim for in IBD. Short-term goals are feeling better and getting blood and poo inflammation tests back to normal. Long-term goals include a healed bowel lining seen at endoscopy, no disability, a normal quality of life, and normal growth in children. Healing through the full bowel wall in Crohn's is not yet a formal target but is a sign of deeper remission.

Topics Monitoring Research Medicines

Jargon explained treat to target endoscopic healing transmural healing biomarker calprotectin CRP clinical remission

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

The Lancet Study Dec 2017 Patients and professionals

CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.

Topics Monitoring Biologics and newer medicines Research

Jargon explained tight control faecal calprotectin CRP mucosal healing treat to target

Crohn's Disease

NHS Lothian Web page For patients

A short page from NHS Lothian's gastroenterology service. It explains that Crohn's most often affects the end of the ileum and the colon, that the inflamed areas are often patchy with healthy bowel in between, and that it can go deeper into the bowel wall than just the lining.

Topics About Crohn's disease

Jargon explained terminal ileum skip lesions transmural remission

The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions

Inflammatory Bowel Diseases Systematic review Oct 2024 Patients and professionals

A team of gut doctors, specialist dietitians and a psychologist reviewed the evidence for the Crohn's Disease Exclusion Diet in children and adults and gave practical advice on using it. They describe it as a whole-food diet that cuts out foods thought to upset gut bacteria and the gut lining. Free to read in full.

Topics Diet and nutrition

Jargon explained exclusion diet gut microbiota intestinal barrier

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (SEQUENCE)

New England Journal of Medicine Study Jul 2024 Patients and professionals

A head-to-head trial in people whose Crohn's had not responded to, or who could not tolerate, anti-TNF drugs. Risankizumab (Skyrizi) was at least as good as ustekinumab (Stelara) for remission at 24 weeks and better at healing the bowel lining by 48 weeks. Side effects looked similar.

Topics Biologics and newer medicines Research

Jargon explained non-inferiority endoscopic remission anti-TNF

Infliximab, azathioprine, or combination therapy for Crohn's disease (SONIC)

New England Journal of Medicine Study Apr 2010 Patients and professionals

A landmark trial of 508 adults with moderate to severe Crohn's who had never had immunosuppressants or biologics. Infliximab and azathioprine together worked best: about 57% were in remission without steroids at 26 weeks, against 44% on infliximab alone and 30% on azathioprine alone. This is why many people starting infliximab are offered a second 'helper' drug alongside it.

Topics Biologics and newer medicines Immunosuppressants Research

Jargon explained combination therapy steroid-free remission mucosal healing randomised controlled trial

The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD)

The Lancet Gastroenterology & Hepatology Study Jan 2022 Patients and professionals

A small pilot trial of 44 adults with mild to moderate Crohn's who had not had biologics. The CDED, with or without supplement drinks, put more than half into remission at 6 weeks, and most of them were still in remission at 24 weeks. About a third had a healed bowel lining. The authors say a bigger trial is needed before firm conclusions.

Topics Diet and nutrition

Jargon explained pilot study open-label endoscopic remission

Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update

ECCO and ESPGHAN (J Crohns Colitis) Guideline Aug 2026 For professionals

The newest European guideline for children with Crohn's, agreed by 27 experts. Children at high risk of a difficult course should start an anti-TNF biologic first, with blood-level checks of the drug. For lower-risk children, a liquid-only diet (EEN) or the Crohn's Disease Exclusion Diet with partial liquid feeds are the preferred first treatments. Long-term goals include a healed bowel lining, normal growth and a good quality of life.

Topics Children and young people Diet and nutrition Biologics and newer medicines Monitoring

Jargon explained anti-TNF therapeutic drug monitoring exclusive enteral nutrition endoscopic remission

Inflammatory Bowel Disease (IBD) telephone advice line service

Cambridge University Hospitals NHS Foundation Trust Leaflet For patients

An example of how a hospital IBD advice line works: a non-urgent, voicemail-first service for treatment questions and flares between clinic appointments. It is explicit that more urgent problems should go to an out-of-hours GP or NHS 111, and clinical emergencies to A&E.

Topics Flare-ups Urgent help Monitoring

Jargon explained ibd advice line ibd nurse specialist

The treatment-naive microbiome in new-onset Crohn's disease

Cell Host & Microbe Study Mar 2014 For professionals

A large study of the gut bacteria of children newly diagnosed with Crohn's, before any treatment. It found a clear pattern: more of certain potentially harmful bacteria and fewer of some helpful groups. Antibiotics made the imbalance worse. Samples from the rectum lining looked promising as a possible early diagnostic test.

Topics About Crohn's disease Research Children and young people

Jargon explained microbiome dysbiosis treatment-naive

Search everything for "mucosa"